PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial

2024-04-24
(Press-News.org) HOUSTON – (April 24, 2024) – Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas in the journal Nature Cancer. 
The therapy uses chimeric antigen receptor (CAR) T cells engineered to target the HER2 protein, which is overexpressed on the surface of sarcoma cells. The HEROS 2.0 trial showed that this therapeutic approach is safe and is associated with clinical benefit.
“CAR T cell therapy has been a highly successful strategy for recurrent or high-risk leukemias or lymphomas, but challenges remain in using this therapy for solid tumors,” said first and corresponding author Dr. Meenakshi Hegde, associate professor of pediatrics – hematology and oncology at Baylor and pediatric oncologist at Texas Children’s Cancer Center. “The results of this trial show that we are moving the dial in harnessing the power of CAR T cells as an effective anticancer therapy for sarcomas.”
In a previous clinical trial, the HEROS study, researchers found that CAR T cells directed at HER2+ tumor cells had a favorable safety profile, but clinical benefit was limited by poor CAR T expansion and persistence. In HEROS 2.0, researchers added successive HER2-CAR T cell infusions following lymphodepletion, which uses chemotherapy to deplete the patient’s own T cells, to make room for the infused therapeutic HER2-CAR T cells to expand.
“We also increased the number of allowable HER2-CAR T infusions to sustain the exposure time of CAR T cells, with the goal of increasing the antitumor effect,” Hegde said. “This study showed that CAR T expansion and persistence was improved with lymphodepletion and repeat cycles of treatment.”
Thirteen patients were enrolled in the HEROS 2.0 trial at Texas Children’s Cancer Center and Houston Methodist Hospital, and seven patients received multiple CAR T infusions. HER2-CAR T expansion occurred following 19 of 21 total infusions, and clinical benefit was seen in 50% of treated patients. An exceptional response in a patient with metastatic rhabdomyosarcoma was detailed in a publication in Nature Communications in 2020. The patient remains healthy and cancer free, more than five years after treatment.
Nine patients in the first two cohorts developed low-grade cytokine release syndrome (CRS), an acute inflammatory response seen as a side effect of CAR T treatment. Two patients in the third cohort experienced dose-limiting CRS, which necessitated ending the dose-escalation.
“We are now studying the tumors and the way we engineer the CAR T cells to better facilitate the safe delivery of higher doses, thereby enhancing antitumor activity by increasing the magnitude of CAR T cell expansion and persistence,” Hegde said.
“HEROS 2.0, the second edition of the HEROS trials, exemplifies how the crosstalk between the bench and the bedside results in refinement of first-in-child studies and more durable clinical benefit,” said senior author Dr. Nabil Ahmed, professor of pediatrics – hematology and oncology at Baylor and pediatric oncologist at Texas Children’s Cancer Center. 
The researchers currently are recruiting for the HEROS 3.0 trial, which will evaluate the safety of giving HER2-CAR T cells in combination with chemotherapy and an immune checkpoint inhibitor drug. Find more information on the trial here.
Hegde and Ahmed both are members of the Dan L Duncan Comprehensive Cancer Center at Baylor. Other study authors include Shoba Navai, Christopher DeRenzo, Sujith K. Joseph, Khaled Sanber, Mengfen Wu, Ahmed Z. Gad, Katherine A. Janeway, Matthew Campbell, Dolores Mullikin, Zeid Nawas, Catherine Robertson, Pretty R. Mathew, Huimin Zhang, Birju Mehta, Raksha R. Bhat, Angela Major, Ankita Shree, Claudia Gerken, Mamta Kalra, Rikhia Chakraborty, Sachin G. Thakar, Olga Dakhova, Vita S. Salsman, Bambi Grilley, Natalia Lapteva, Adrian Gee, Gianpietro Dotti, Riyue Bao, Ahmed Hamed Salem, Tao Wang, Malcolm K. Brenner, Helen E. Heslop, Winfried S. Wels, M. John Hicks and Stephen Gottschalk. They are affiliated with one or more of the following institutions: Baylor College of Medicine, Texas Children’s Cancer and Hematology Center, the Center for Cell and Gene Therapy, the Dan L Duncan Comprehensive Cancer Center, Dana Farber Cancer Institute, University of North Carolina at Chapel Hill, University of Pittsburgh, UPMC Hillman Cancer Center, Ain Shams University, Georg-Speyer-Haus Institute for Tumor Biology and Experimental Therapy, German Cancer Consortium, Frankfurt Cancer Institute and St. Jude Children’s Research Hospital.
This work was supported in part by Stand Up To Cancer (SU2C) – St. Baldrick’s Pediatric Cancer Dream Team Translational Research Grant (SU2C-AACR-DT1113), the V Foundation for Cancer Research, Triumph Over Kids Cancer Foundation (TOKC), Cookies for Kids’ CancerTM Foundation, Alex’s Lemonade Stand Pediatric Cancer Foundation, the Faris Foundation, National Cancer Institute and the Cancer Prevention and Research Institute of Texas. See the publication for a complete list of funding sources.
# # #
 

END


ELSE PRESS RELEASES FROM THIS DATE:

Social change may explain decline in genetic diversity of the Y chromosome at the end of the Neolithic period

Social change may explain decline in genetic diversity of the Y chromosome at the end of the Neolithic period
2024-04-24
The emergence in the Neolithic of patrilineal1 social systems, in which children are affiliated with their father's lineage, may explain a spectacular decline in the genetic diversity of the Y chromosome2 observed worldwide between 3,000 and 5,000 years ago. In a study to be published on 24 April in Nature Communications, a team of scientists from the CNRS, MNHN and Université Paris Cité3 suggest that these patrilineal organisations had a greater impact on the Y chromosome than mortality during conflict. This ...

Aston University research finds that social media can be used to increase fruit and vegetable intake in young people

2024-04-24
The research team asked one group of participants to follow healthy eating accounts and another to follow interior design accounts After just two weeks, participants following healthy eating accounts ate more fruit and vegetables and less junk food Even minor tweaks to social media accounts could result in substantial diet improvements in young adults. Researchers from Aston University have found that people following healthy eating accounts on social media for as little as two weeks ate more fruit and vegetables and less junk food. Previous ...

A vaccine to fight antibiotic resistance

A vaccine to fight antibiotic resistance
2024-04-24
Driven by the overuse of antimicrobials, pathogens are quickly building up resistances to once-successful treatments. It’s estimated that antimicrobial-resistant infections killed more than 1 million people worldwide in 2019, according to the World Health Organization.    “There are worries that at the rate things are going, in perhaps 20 or 30 years, few of our drugs will be effective at all,” said Xuefei Huang, a Michigan State University Research Foundation Professor in the departments ...

European Hormone Day 2024: Endocrine community unites to raise public awareness and push for policy action on hormone health

European Hormone Day 2024: Endocrine community unites to raise public awareness and push for policy action on hormone health
2024-04-24
European Hormone Day 2024: Endocrine community unites to raise public awareness and push for policy action on hormone health European Hormone Day returns for the third year today, 24 April 2024, putting a spotlight on the vital role of hormones in chronic diseases such as diabetes, thyroid disorders, cancer and obesity, as well as many rare diseases. The European Society of Endocrinology (ESE), the European Hormone and Metabolism Foundation (ESE Foundation), and partners from key groups and organisations across Europe and beyond will join forces to highlight simple steps we can all take towards better hormone health. This builds on the success of the previous ...

Good heart health in middle age may preserve brain function among Black women as they age

2024-04-24
Research Highlights: Middle-aged Black women with better heart health were less likely to show a decline in mental function compared with middle-aged Black women with worse heart health. In this study, heart health was unrelated to cognitive decline among middle-aged white women. A clinical trial is required to confirm if improving heart health among middle-aged Black women may slow cognitive decline and decrease the risk of dementia. Embargoed until 2 a.m. CT/3 a.m. ET Wednesday, April 24, 2024 DALLAS, April 24, 2024 ...

The negative effects of racism impact sleep in adolescents

2024-04-24
Sleep and sleep disturbances have consequences for the development of adolescents and young adults. In a new article, researchers examine sleep during these periods, focusing on the effects of ethnic and racial discrimination. They conclude that improving sleep may boost health for all youth, but especially for those affected by racism. The article, by researchers at Fordham University and the University of Illinois at Urbana-Champaign, appears in Child Development Perspectives, a journal of the Society for Research in Child Development. “Discrimination ...

Study uses wearable devices to examine 3- to 6-year-olds’ impulsivity, inattentiveness

2024-04-24
Why do some young children struggle to sit through a story one day but not the next? Why do they rush impulsively into one activity but not another? Parents and teachers often focus on individual differences as they prepare children for formal schooling, but traditional measurement approaches make it difficult to study fluctuations in children’s behavior. In a new study, researchers sought to understand children’s impulsive and inattentive behaviors in early education classrooms by having students use wearable devices called accelerometers to collect an intensive time series of their movement at school. The study found that children modulated their ...

Will future hurricanes compromise New England forests’ ability to store and sequester carbon?

2024-04-24
Nature-based climate solutions can help mitigate climate change, especially in forested regions capable of storing and sequestering vast amounts of carbon. New research published in Global Change Biology indicates that a single hurricane in New England, one of the most heavily forested regions in the United States, can down 4.6–9.4% of the total aboveground forest carbon, an amount much greater than the carbon sequestered annually by New England’s forests. The work revealed that emissions from hurricanes are not instantaneous—it takes approximately 19 years for downed carbon to become a net emission, and 100 years for 90% of the downed carbon ...

Longest study to date assesses cognitive impairment over time in adults with essential tremor

2024-04-24
Essential tremor, a nervous system disorder that causes rhythmic shaking, is one of the most common movement disorders. A new study published in the Annals of Neurology reveals details on the increased risk of mild cognitive impairment (MCI) and dementia that individuals with essential tremor may face. The research represents the longest available longitudinal prospective study of rates of MCI and dementia in people with essential tremor. The study enrolled 222 patients, 177 of whom participated in periodic evaluations over an average follow-up of 5 years. Investigators observed ...

Does a woman’s heart health affect cognition in midlife?

2024-04-24
A new study has found that Black women with poor cardiovascular health may face an elevated risk of early signs of cognitive decline in midlife. The study, which is published in the Journal of the American Heart Association, included 363 Black and 402 white women who enrolled in the Chicago site of the Study of Women’s Health Across the Nation when they were 42–52 years old. Cognition (measured as processing speed and working memory) was assessed annually or biennially over a maximum of 20 years, with an average follow-up of 9.8 years. A composite index of cardiovascular health (Life’s Essential 8) was calculated ...

LAST 30 PRESS RELEASES:

Algorithms could help improve judicial decisions

Scientists uncover a multibillion-year epic written into the chemistry of life

Monitoring diseases through sweat becomes accessible to everyone

Mathematical model driven evolutionary therapy dosing exploiting cancer cell plasticity

Biodiversity in the margins: Merging farmlands affects natural pest control

1 in 8 pregnant people have a disability, but significant gaps exist in the provision of accessible care

Statins associated with decreased risk for CVD and death, even in very old adults

Climate change is moving tree populations away from the soil fungi that sustain them

Secrets of sargassum: Scientists advance knowledge of seaweed causing chaos in the Caribbean and West Africa

Bioinformatics approach could help optimize soldiers’ training for improved readiness and recovery

Earth scientists describe a new kind of volcanic eruption

Warmer wetter climate predicted to bring societal and ecological impact to the Tibetan Plateau

Feeding infants peanut products protects against allergy into adolescence

Who will like beetle skewers? What Europeans think about alternative protein food

ETRI wins ‘iF Design Award’ for mobile collaborative robot

Combating carbon footprint: novel reactor system converts carbon dioxide into usable fuel

Investigating the origin of circatidal rhythms in freshwater snails

Altering cellular interactions around amyloid plaques may offer novel Alzheimer’s treatment strategies

Brain damage reveals part of the brain necessary for helping others

Surprising properties of elastic turbulence discovered

Study assesses cancer-related care at US hospitals predominantly serving minority populations compared with non-minority serving hospitals

First in-human investigator-initiated clinical trial to launch for refractory prostate cancer patients: Novel alpha therapy targets prostate-specific membrane antigen

Will generative AI change the way universities communicate?

Artificial Intelligence could help cure loneliness, says expert

Echidnapus identified from an ‘Age of Monotremes’

Semaglutide may protect kidney function in individuals with overweight or obesity and cardiovascular disease

New technique detects novel biomarkers for kidney diseases with nephrotic syndrome

Political elites take advantage of anti-partisan protests to disrupt politics

Tiny target discovered on RNA to short-circuit inflammation, UC Santa Cruz researchers find

Charge your laptop in a minute? Supercapacitors can help; new research offers clues

[Press-News.org] CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial